Research on mechanisms suggest that low serum testosterone decreases insulin resistance indirectly by promoting metabolically favourable changes in body composition [36]; and directly by enhancing catecholamine-induced lipolysis in vitro [37] and reducing lipoprotein lipase activity and triglyceride uptake in human abdominal adipose tissue in vivo [38]. The gene discussed is LPL; the disease is Insulin resistance.